BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9387040)

  • 1. Matrix metalloproteinase inhibitors: present achievements and future prospects.
    Denis LJ; Verweij J
    Invest New Drugs; 1997; 15(3):175-85. PubMed ID: 9387040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase inhibitors.
    Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
    Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.
    Rasmussen HS; McCann PP
    Pharmacol Ther; 1997; 75(1):69-75. PubMed ID: 9364582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase inhibitors: applications in oncology.
    Yip D; Ahmad A; Karapetis CS; Hawkins CA; Harper PG
    Invest New Drugs; 1999; 17(4):387-99. PubMed ID: 10759405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of matrix metalloproteinase inhibitors in cancer therapy.
    Hidalgo M; Eckhardt SG
    J Natl Cancer Inst; 2001 Feb; 93(3):178-93. PubMed ID: 11158186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase inhibition: a review of anti-tumour activity.
    Brown PD; Giavazzi R
    Ann Oncol; 1995 Dec; 6(10):967-74. PubMed ID: 8750146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase inhibitors: a novel class of anticancer agents.
    Brown PD
    Adv Enzyme Regul; 1995; 35():293-301. PubMed ID: 7572350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer.
    Talbot DC; Brown PD
    Eur J Cancer; 1996 Dec; 32A(14):2528-33. PubMed ID: 9059343
    [No Abstract]   [Full Text] [Related]  

  • 9. Matrix metalloproteinases. Novel targets for directed cancer therapy.
    Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
    Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase inhibitors as anticancer agents.
    Konstantinopoulos PA; Karamouzis MV; Papatsoris AG; Papavassiliou AG
    Int J Biochem Cell Biol; 2008; 40(6-7):1156-68. PubMed ID: 18164645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
    Wojtowicz-Praga S; Low J; Marshall J; Ness E; Dickson R; Barter J; Sale M; McCann P; Moore J; Cole A; Hawkins MJ
    Invest New Drugs; 1996; 14(2):193-202. PubMed ID: 8913840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of matrix metalloproteinases in patients with malignant tumors].
    Stanciƫte D; Didziapetriene J; Kadziauskas J
    Medicina (Kaunas); 2004; 40(12):1143-50. PubMed ID: 15630339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase inhibitors.
    Ramnath N; Creaven PJ
    Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.
    Pavlaki M; Zucker S
    Cancer Metastasis Rev; 2003; 22(2-3):177-203. PubMed ID: 12784996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Batimastat. BB 94, collagenase inhibitors-1.
    Drugs R D; 1999 Feb; 1(2):139-41. PubMed ID: 10566008
    [No Abstract]   [Full Text] [Related]  

  • 18. Matrix metalloproteinase inhibitors.
    Brown PD
    Breast Cancer Res Treat; 1998; 52(1-3):125-36. PubMed ID: 10066077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
    Coussens LM; Fingleton B; Matrisian LM
    Science; 2002 Mar; 295(5564):2387-92. PubMed ID: 11923519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase inhibitors in the treatment of cancer.
    Brown PD
    Med Oncol; 1997 Mar; 14(1):1-10. PubMed ID: 9232605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.